TLSI
TriSalus Life Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.10
+4.08%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $14.3M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.16
- EPS estimate
- -$0.15
- Revenue actual
- $11.4M
- Revenue estimate
- $10.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -139.7%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.15 | -$0.16 | Miss -3.23% | $11.4M |
| May 12, 2026 | -$0.16 | -$0.33 | Miss -106.25% | $8.9M |
| Mar 5, 2026 | -$0.14 | -$0.12 | Beat 15.49% | $13.2M |
| Nov 13, 2025 | -$0.17 | -$0.96 | Miss -464.71% | $11.6M |
| Aug 12, 2025 | -$0.22 | -$0.27 | Miss -22.73% | $11.2M |
| May 15, 2025 | -$0.20 | -$0.33 | Miss -65.00% | $9.2M |
| Mar 27, 2025 | -$0.35 | -$0.35 | In line | $8.3M |
| Nov 14, 2024 | -$0.36 | -$0.40 | Miss -11.11% | $7.3M |
| Aug 14, 2024 | -$0.49 | -$0.21 | Beat 57.14% | $7.4M |
| May 15, 2024 | -$0.65 | -$0.54 | Beat 16.92% | $6.5M |
| Feb 27, 2024 | — | -$1.34 | — | $5.7M |
| Nov 14, 2023 | — | -$0.13 | — | $5.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026